CAPITELLI SARA B 4
4 · CASI Pharmaceuticals, Inc. · Filed Apr 13, 2018
Insider Transaction Report
Form 4
CAPITELLI SARA B
VP, Finance and PAO
Transactions
- Exercise/Conversion
Common Stock
2018-04-12$0.88/sh+26,978$23,741→ 26,978 total - Tax Payment
Common Stock
2018-04-12$6.62/sh−8,200$54,284→ 18,778 total - Disposition to Issuer
Common Stock
2018-04-12$6.62/sh−18,778$124,310→ 0 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2018-04-12−26,978→ 0 totalExercise: $0.88Exp: 2026-03-02→ Common Stock (26,978 underlying)
Footnotes (1)
- [F1]These stock options are the vested portion of stock options that were granted on March 2, 2016 which vested or will vest as follows: 25% on the date of grant, and the remainder ratably over three years on a monthly basis.